IRhythm Technologies Income from Continuous Operations 2015-2025 | IRTC

IRhythm Technologies income from continuous operations for the twelve months ending June 30, 2025 was $-0.092B, a 29.76% decline year-over-year.

  • IRhythm Technologies annual income from continuous operations for 2024 was $-0.113B, a 8.2% decline from 2023.
  • IRhythm Technologies annual income from continuous operations for 2023 was $-0.123B, a 6.24% increase from 2022.
  • IRhythm Technologies annual income from continuous operations for 2022 was $-0.116B, a 14.6% increase from 2021.

IRhythm Technologies Income from Continuous Operations 2015-2025 | IRTC

  • IRhythm Technologies annual income from continuous operations for 2024 was $-0.113B, a 8.2% decline from 2023.
  • IRhythm Technologies annual income from continuous operations for 2023 was $-0.123B, a 6.24% increase from 2022.
  • IRhythm Technologies annual income from continuous operations for 2022 was $-0.116B, a 14.6% increase from 2021.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.1B
Tempus AI (TEM)$13.6B
Doximity (DOCS)$12.3B
Hims & Hers Health (HIMS)$10.2B
Hinge Health (HNGE)$4.6B
Privia Health (PRVA)$2.6B
Inspire Medical Systems (INSP)$2.6B
Heartflow (HTFL)$2.4B
Phreesia (PHR)$1.7B
Enovis (ENOV)$1.7B
10x Genomics (TXG)$1.7B
Schrodinger (SDGR)$1.5B
Omnicell (OMCL)$1.5B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.3B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$659M
Zepp Health (ZEPP)$630M
Veradigm (MDRX)$503M
Standard BioTools (LAB)$482M
Talkspace (TALK)$435M
Butterfly Network (BFLY)$363M
Carlsmed (CARL)$349M
TruBridge (TBRG)$290M
Outset Medical (OM)$243M
SOPHiA GENETICS SA (SOPH)$236M
Nyxoah SA (NYXH)$224M
Health Catalyst (HCAT)$211M
KORU Medical Systems (KRMD)$195M